NCT07158450
Novel On-body Evaluation of Cardiac Health for Oncology
Enrolling by Invitation
Not specifiedAges 18+ObservationalSkribe Medical
~500 participants
Updated 2026-05-20 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Correlation between wearable-derived and transthoracic echocardiography-derived left ventricular ejection fraction estimates
Measured over From baseline through study completion (up to 6 months) at each paired assessment
Conditions
Where it's being run
7 sites across 7 statesColorado1
Florida1
Illinois1
Louisiana1
New York1
Pennsylvania1
Tennessee1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Undergoing an echocardiogram irrespective of participation in this study
Willing and able to provide informed consent prior to any study-related activity
Exclusion
Have a documented allergy to potential tissue contacting system materials
Have any condition that would cause inaccurate TTE measurements
What this trial measures
- Correlation between wearable-derived and transthoracic echocardiography-derived left ventricular ejection fraction estimatesFrom baseline through study completion (up to 6 months) at each paired assessment
The primary analysis will compute the correlation coefficient (r) between wearable-derived model estimates of LVEF and transthoracic echocardiography-derived LVEF in the Hold-Out Test Set. The prespecified performance target is r \> 0.70.